Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating FieldsDisease Attributes, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumorActive, not recruitingPhase 22026-08-10NCT04469075

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Memorial Sloan Kettering Cancer Center753

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Columbia UniversityNew YorkUnited States154
Hackensack Meridian HealthHackensackUnited States22
Memorial Sloan Kettering Cancer CenterNew YorkUnited States60
Memorial Sloan Kettering Cancer Center Suffolk - Hauppauge (All Protocol Activities)HauppaugeUnited States1
Northwestern UniversityEvanstonUnited States53
Tufts Medical CenterBostonUnited States238
University of Cincinnati Medical CenterCincinnatiUnited States83
Washington University School of MedicineSt LouisUnited States895